Treasury season, but make it crypto
Lite Strategy — the newly rebranded MEI Pharma — just added 929,548 LTC to its corporate treasury and officially marked Litecoin as a reserve asset. That’s the kind of headline that makes crypto desks sit up, because when a public company starts hoarding your coin, it tends to light a match under the narrative.
The ETF rumor machine is back on
The article says Bloomberg Intelligence is now putting U.S. spot LTC ETF approval odds in the 75% to 90% range, with the SEC already clearing LTC for spot listing under new generic standards, per CCN. Translation: the market is starting to believe Litecoin could get the same institutional on-ramp treatment that helped other major crypto assets catch a bid.
Why investors care
If you own LTC, this is the classic two-step:
- a public company adds it to treasury, which helps the “legit asset” story
- ETF approval odds rise, which can bring in fresh flows if the SEC actually says yes
That combination has traders dusting off old price targets like $60, $80, and whatever moon math they can justify before lunch. And yes, the piece also throws Pepeto into the mix, but that’s more presale-hype side quest than Litecoin itself.
Big picture
Litecoin hasn’t exactly been the main character for a while. But treasury adoption plus ETF buzz is how a boring chart suddenly gets a plot twist — and in crypto, plot twists are often the whole game.